Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
francesco.marampon@uniroma1.it
Francesco Marampon
Professore Associato
Struttura:
DIPARTIMENTO DI SCIENZE RADIOLOGICHE, ONCOLOGICHE E ANATOMO-PATOLOGICHE
E-mail:
francesco.marampon@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Synergistic effects of PARP inhibitors and ionizing radiation on growth and survival of rhabdomyosarcoma cells
ANNALS OF ONCOLOGY
2018
Oral platelet gel supernatant plus supportive medical treatment versus supportive medical treatment in the management of radiation-induced oral mucositis: a matched explorative active control trial by propensity analysis
AMERICAN JOURNAL OF CLINICAL ONCOLOGY: CANCER CLINICAL TRIALS
2017
HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells
CANCER LETTERS
2017
Testosterone insulin-like effects: an in vitro study on the short-term metabolic effects of testosterone in human skeletal muscle cells
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
2017
Radiation therapy and serum salivary amylase in head and neck cancer
ONCOTARGET
2017
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells
JOURNAL OF HEMATOLOGY & ONCOLOGY
2017
Defective DNA repair mechanisms in prostate cancer: impact of olaparib
DRUG DESIGN, DEVELOPMENT AND THERAPY
2017
The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma
JOURNAL OF HEMATOLOGY & ONCOLOGY
2017
The first negative allosteric modulator for dopamine D2 and D3 receptors, SB269652 may lead to a new generation of antipsychotic drugs
MOLECULAR PHARMACOLOGY
2017
Enhancement of radiosensitivity by the novel anticancer quinolone derivative vosaroxin in preclinical glioblastoma models
ONCOTARGET
2017
The novel CXCR4 antagonist, PRX177561, reduces tumor cell proliferation and accelerates cancer stem cell differentiation in glioblastoma preclinical models
TUMOR BIOLOGY
2017
The possible prognostic role of histone deacetylase and transforming growth factor β/Smad signaling in high grade gliomas treated by radio-chemotherapy: a preliminary immunohistochemical study
EUROPEAN JOURNAL OF HISTOCHEMISTRY
2017
Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer
ONCOTARGET
2017
Episode-like pulse testosterone supplementation induces tumor senescence and growth arrest down-modulating androgen receptor through modulation of p-ERK1/2, pAR ser81 and CDK1 signaling: biological implications for men treated with testosterone replacement therapy
ONCOTARGET
2017
Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgenindependent prostate cancer cells to DNA damage
ONCOTARGET
2016
c-Myc sustains transformed phenotype and promotes radioresistance of embryonal rhabdomyosarcoma cell lines
RADIATION RESEARCH
2016
Treatment of osteolytic solitary painful osseous metastases with radiofrequency ablation or cryoablation: a retrospective study by propensity analysis
ONCOLOGY LETTERS
2016
Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population
MOLECULAR CANCER
2016
Vitamin D protects endothelial cells from irradiation-induced senescence and apoptosis by modulating MAPK/SirT1 axis
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
2016
DNMT3B in vitro knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation
ONCOTARGET
2016
« prima
< precedente
1
2
3
4
5
6
7
seguente ›
ultima »
Progetti di Ricerca
Coding and non-coding genes driving radio-resistance mechanisms in rhabdomyosarcoma tumors: cues to new biomarkers and therapeutic targets.
Identifying and targeting pathways involved in radio-resistance in pediatric rhabdomyosarcoma
HDACs inhibitors as radiosensitizers for rhabdomyocarcoma cancer therapy
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma